华大基因：持股比例被动稀释至31.3223%

Core Viewpoint - The announcement from BGI Genomics indicates that BGI Holdings and its concerted parties hold a total of 131 million shares, representing 31.3223% of the company's total equity. This change in equity ownership is a result of the company's stock issuance to specific parties and the completion of the second phase of the 2022 restricted stock incentive plan, which led to a passive dilution of the shareholding percentage for the information disclosure obligors. There are currently no clear plans or agreements to increase or decrease their equity stake in the listed company within the next 12 months [1]. Group 1 - BGI Holdings and its concerted parties collectively own 131 million shares, accounting for 31.3223% of the total equity [1] - The change in ownership percentage is due to stock issuance and the completion of the restricted stock incentive plan [1] - There are no immediate plans to alter the equity stake in the next 12 months [1]